Hepatic and intestinal schistosomiasis after orthotopic liver transplant

Liver Transplantation

Volumn 11, Issue 12, 2005, Pages 1603-1607

  Hoare, Matthew ^a   Gelson, William T H ^a   Davies, Susan E ^a   Curran, Martin ^a   Alexander, Graeme J M ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; PEGINTERFERON ALPHA2B; PRAZIQUANTEL; PREDNISOLONE; RAPAMYCIN; RIBAVIRIN; TACROLIMUS; WARFARIN;

ADULT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; ENDEMIC DISEASE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; INTESTINE; LIVER DISEASE; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MALE; PARASITE IDENTIFICATION; PATHOPHYSIOLOGY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SCHISTOSOMIASIS; SCREENING TEST; STOMACH BIOPSY; STOMACH DISEASE;

ANIMALS; ANTHELMINTICS; ANTIBODIES, HELMINTH; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER DISEASES, PARASITIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PRAZIQUANTEL; SCHISTOSOMA; SCHISTOSOMIASIS MANSONI;

EID: 30444455921     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20622     Document Type: Article

References (28)

1. The World Health Organization. The World Health Report 2002. 2002.
2. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003;86:125-139.
3. Bica I, Hamer DH, Stadecker MJ. Hepatic schistosomiasis. Infect Dis Clin North Am 2000;14:583-604,viii.
4. Amiri P, Locksley RM, Parslow TG, Sadick M, Rector E, Ritter D, et al. Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 1992;356:604-607.
5. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355:887-891.
6. Gad A, Tanaka E, Orii K, Rokuhara A, Nooman Z, Serwah AH, et al. Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect. J Gastroenterol 2001;36:753-758.
7. Khalaf H, Farag S, El-Hussainy E. Long-term follow-up after liver transplantation in Egyptians transplanted abroad. Saudi Med J 2004;25:1931-1934.
8. Kayler LK, Rudich SM, Merion RM. Orthotopic liver transplantation from a donor with a history of schistosomiasis. Transplant Proc 2003;35:2974-2976.
9. Strickland GT. Gastrointestinal manifestations of schistosomiasis: Gut 1994;35:1334-1337.
10. Bedwani R, El-Khwsky F, EL-Shazly M, Seif HA, Zaki A, Renganathan E, et al. Hepatitis viruses, schistosomal infection and liver cancer in Egypt. Int J Cancer 1996;68:688-689.
11. Waked IA, Saleh SM, Moustafa MS, Raouf AA, Thomas DL, Strickland GT. High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut 1995;37:105-107.
12. Helal TE, Danial MF, Ahmed HF. The relationship between hepatitis C virus and schistosomiasis: Histopathologic evaluation of liver biopsy specimens. Hum Pathol 1998;29:743-749.
13. Pereira LM, Melo MC, Saleh MG, Massarolo P, Koskinas J, Domingues AL, et al. Hepatitis C virus infection in Schistosomiasis mansoni in Brazil. J Med Virol 1995;45:423-428.
14. Halim AB, Garry RF, Dash S, Gerber MA. Effect of schistosomiasis and hepatitis on liver disease. Am J Trop Med Hyg 1999; 60:915-920.
15. Shoukry NH, Cawthon AG, Walker CM. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol 2004;58:391-424.
16. Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev 2004; 201:156-167.
17. Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, Berzofsky JA. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A 1993;90:948-952.
18. Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, Lewis FA, et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995;376: 594-596.
19. Kamal SM, Rasenack JW, Bianchi L, Al TA, El Sayed KK, Peter T, et al. Acute hepatitis C without and with schistosomiasis: Correlation with hepatitis C-specific CD4(+) T-cell and cytokine response. Gastroenterology 2001;121:646-656.
20. Maizels RM, Bundy DA, Selkirk ME, Smith DF, Anderson RM. Immunological modulation and evasion by helminth parasites in human populations. Nature 1993;365:797-805.
21. Parana R, Codes L, Andrade Z. Is splenectomy a cause of antiviral treatment failure in hepatitis C virus infection? Hepatology 2001;33:1340.
22. el Shiekh Mohamed AR, al Karawi MA, Yasawy MI. Organ involvement in hepato-intestinal schistosomiasis. Hepatogastroenterology 1994;41:370-376.
23. Mahmoud KM, Sobh MA, El-Agroudy AE, Mostafa FE, Baz ME, Shokeir AA, et al. Impact of schistosomiasis on patient and graft outcome after renal transplantation: 10 years' follow-up. Nephrol Dial Transplant 2001;16:2214-2221.
24. Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ. Short report: Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 1995;53:61-62.
25. Liang YS, Coles GC, Doenhoff MJ. Detection of praziquantel resistance in schistosomes. Trop Med Int Health 2000;5:72.
26. Caffrey CR, Gsell C, Ruppel A. Schistosoma japonicum is less sensitive to cyclosporin A in vivo than Schistosoma mansoni. J Parasitol 1999;85:736-739.
27. Utzinger J, Booth M, N'Goran EK, Muller I, Tanner M, Lengeler C. Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology 2001;122(Pt 5):537-544.
28. Doenhoff MJ, Chiodini PL, Hamilton JV. Specific and sensitive diagnosis of schistosome infection: Can it be done with antibodies? Trends Parasitol 2004;20:35-39.